Latest News in the pharma Industry

Research & Development

Study Finds that Microinjection Platform Enables Assessment of Multiple Cancer Drugs Directly in Tumours

Study Finds that Microinjection Platform Enables Assessment of Multiple Cancer Drugs Directly in Tumours

23 Apr 2015

Read more 
Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015

21 Apr 2015

Read more 
Merck Submits Supplemental Biologics License Application FDA for Keytruda (Pembrolizumab) in Advanced NSCLC

Merck Submits Supplemental Biologics License Application FDA for Keytruda (Pembrolizumab) in Advanced NSCLC

21 Apr 2015

Read more 
Real World' Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC

Real World' Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC

21 Apr 2015

Read more 
FDA Calls Upon Genervon to Release All Trial Data

FDA Calls Upon Genervon to Release All Trial Data

20 Apr 2015

Read more 
Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone

17 Apr 2015

Read more 
Selvita to Release the Most Recent Results from Its Oncology Programs at the AACR Annual Meeting 2015

Selvita to Release the Most Recent Results from Its Oncology Programs at the AACR Annual Meeting 2015

17 Apr 2015

Read more 
New Pre-validated Fluorinated Fragment Library Boosts Drug Screening Efficiency

New Pre-validated Fluorinated Fragment Library Boosts Drug Screening Efficiency

15 Apr 2015

Read more 
Recruiting the Entire Immune System to Attack Cancer

Recruiting the Entire Immune System to Attack Cancer

15 Apr 2015

Read more 
FDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers

FDA Modifies Partial Clinical Hold on Tekmira's TKM-Ebola IND to Allow Multiple Dosing of Healthy Volunteers

13 Apr 2015

Read more 
Rhythm Initiates Phase IIb Clinical Trial of Relamorelin for Diabetic Gastroparesis

Rhythm Initiates Phase IIb Clinical Trial of Relamorelin for Diabetic Gastroparesis

13 Apr 2015

Read more 
FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults

FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults

10 Apr 2015

Read more